Vault-13

Paradigm Biocapital Advisors LP

NEW YORK, NY · CIK 1855655 · 13F filing filed 2022-02-14

SEC-registered investment adviser since 2021 · limited partnership

As an employer

$350.2m reported value
24positions
67.0%in top 10
—no comparable previous quarter

Holdings, Q4 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 MIRATI THERAPEUTICS INC COM MRTX MRTX 260,115 $38.2m10.90% 10.90% First filing
2 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 218,158 $29.3m8.38% 8.38% First filing
3 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 300,434 $25.3m7.21% 7.21% First filing
4 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,209,051 $23.9m6.83% 6.83% First filing
5 ARENA PHARMACEUTICALS INC COM NEW ARNA ARNA 251,777 $23.4m6.68% 6.68% First filing
6 GLOBAL BLOOD THERAPEUTICS IN COM GBT GBT 780,480 $22.8m6.52% 6.52% First filing
7 ARVINAS INC COM ARVN ARVN 268,519 $22.1m6.30% 6.30% First filing
8 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 385,967 $18.0m5.14% 5.14% First filing
9 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 844,005 $16.1m4.60% 4.60% First filing
10 SEAGEN INC COM SGEN SGEN 100,687 $15.6m4.45% 4.45% First filing
11 ARGENX SE SPONSORED ADR ARGX ARGX 42,050 $14.7m4.21% 4.21% First filing
12 IVERIC BIO INC COM OPHT OPHT 815,581 $13.6m3.89% 3.89% First filing
13 INSMED INC COM PAR $.01 INSM INSM 394,358 $10.7m3.07% 3.07% First filing
14 SIERRA ONCOLOGY INC COM NEW COM NEW 474,945 $10.3m2.95% 2.95% First filing
15 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 453,091 $9.9m2.83% 2.83% First filing
16 GALAPAGOS NV SPON ADR LKFT LKFT 167,824 $9.3m2.64% 2.64% First filing
17 C4 THERAPEUTICS INC COM STK CCCC CCCC 258,746 $8.3m2.38% 2.38% First filing
18 KYMERA THERAPEUTICS INC COM KYMR KYMR 125,858 $8.0m2.28% 2.28% First filing
19 VOR BIOPHARMA INC COM COM 629,342 $7.3m2.09% 2.09% First filing
20 ENANTA PHARMACEUTICALS INC COM ENTA ENTA 75,507 $5.6m1.61% 1.61% First filing
21 OYSTER PT PHARMA INC COM OYST OYST 304,238 $5.6m1.59% 1.59% First filing
22 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 134,249 $4.6m1.31% 1.31% First filing
23 ESPERION THERAPEUTICS INC NE COM ESPR ESPR 839,257 $4.2m1.20% 1.20% First filing
24 GRACELL BIOTECHNOLOGIES INC SPONSORED ADS SPONSORED ADS 545,388 $3.3m0.94% 0.94% First filing

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
OLEMA PHARMACEUTICALS INC OLMA · 13G · filed 2025-02-14 OLMA 10.0%≈ $92.9m 13G 2025-02-14
EDGEWISE THERAPEUTICS INC EWTX · 13G · filed 2026-08-14 EWTX 9.5%≈ $415.1m +3.3 pts 13G 2026-08-14
ACHIEVE LIFE SCIENCES INC ACHV · 13G · filed 2026-04-24 ACHV 9.2%≈ $64.7m new 13G 2026-04-24
ASSEMBLY BIOSCIENCES INC ASMB · 13G · filed 2026-08-14 ASMB 7.8%≈ $42.7m +2.4 pts 13G 2026-08-14
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-08-14 VRDN 6.1%≈ $123.5m +1.0 pts 13G 2026-08-14
TYRA BIOSCIENCES INC TYRA · 13G · filed 2026-09-17 TYRA 5.8%≈ $110.9m new 13G 2026-09-17
LEXEO THERAPEUTICS INC LXEO · 13G · filed 2026-08-14 LXEO 5.3%≈ $19.4m -3.0 pts 13G 2026-08-14
MBX BIOSCIENCES INC MBX · 13G · filed 2026-06-24 MBX 5.2%≈ $137.6m new 13G 2026-06-24
SPYRE THERAPEUTICS INC SYRE · 13G · filed 2026-10-01 SYRE 5.1%≈ $395.7m new 13G 2026-10-01
JADE BIOSCIENCES INC JBIO · 13G · filed 2026-07-17 JBIO 5.1%≈ $69.0m new 13G 2026-07-17